- Home
- QURE vs PGY Comparison
QURE vs PGY Comparison
Compare QURE & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- PGY
- Stock Information
- Founded
- QURE 1998
- PGY 2016
- Country
- QURE Netherlands
- PGY United States
- Employees
- QURE N/A
- PGY N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- PGY Finance: Consumer Services
- Sector
- QURE Health Care
- PGY Finance
- Exchange
- QURE Nasdaq
- PGY Nasdaq
- Market Cap
- QURE 725.4M
- PGY 863.7M
- IPO Year
- QURE 2007
- PGY N/A
- Fundamental
- Price
- QURE $14.28
- PGY $22.18
- Analyst Decision
- QURE Strong Buy
- PGY Strong Buy
- Analyst Count
- QURE 10
- PGY 8
- Target Price
- QURE $37.20
- PGY $23.19
- AVG Volume (30 Days)
- QURE 1.2M
- PGY 2.4M
- Earning Date
- QURE 07-31-2025
- PGY 08-08-2025
- Dividend Yield
- QURE N/A
- PGY N/A
- EPS Growth
- QURE N/A
- PGY N/A
- EPS
- QURE N/A
- PGY N/A
- Revenue
- QURE $20,201,000.00
- PGY $1,076,961,000.00
- Revenue This Year
- QURE N/A
- PGY $20.61
- Revenue Next Year
- QURE $278.91
- PGY $13.33
- P/E Ratio
- QURE N/A
- PGY N/A
- Revenue Growth
- QURE 6.30
- PGY 23.69
- 52 Week Low
- QURE $3.73
- PGY $8.20
- 52 Week High
- QURE $19.18
- PGY $23.45
- Technical
- Relative Strength Index (RSI)
- QURE 47.07
- PGY 72.61
- Support Level
- QURE $13.65
- PGY $21.05
- Resistance Level
- QURE $14.46
- PGY $20.60
- Average True Range (ATR)
- QURE 0.78
- PGY 1.14
- MACD
- QURE -0.18
- PGY 0.22
- Stochastic Oscillator
- QURE 27.21
- PGY 78.83
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.